BIM
ACUR

BlackRock Investment Management’s Acura Pharmaceuticals ACUR Stock Holding History

BlackRock Investment Management’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-763
Closed -$3K – 4250
2015
Q1 		$3K Sell
763
-260
-25% -$830 ﹤0.01% 3955
2014
Q4 		$2K Hold
1,023
– – ﹤0.01% 4068
2014
Q3 		$4K Buy
1,023
+188
+23% +$882 ﹤0.01% 3958
2014
Q2 		$5K Buy
+835
New +$5.06K ﹤0.01% 3895

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
IB
Intrust Bank Wichita, Kansas $1.35B AUM 37.16% 1-Year Est. Return

BlackRock Investment Management's ACUR Position: Q2 2015 in Review

BlackRock Investment Management sold out of Acura Pharmaceuticals (ACUR) in Q2 2015, closing a stake of 763 shares — an estimated $3K sold.

BlackRock Investment Management first reported a position in ACUR in Q2 2014 and held it in 4 quarters. The position peaked at $5K in Q2 2014. 27 funds tracked by Wall St. Rank hold ACUR as of Q2 2015.

  • BlackRock Investment Management reported no remaining Acura Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • BlackRock Investment Management sold 763 Acura Pharmaceuticals shares in Q2 2015, an estimated $3K.
  • BlackRock Investment Management first reported a position in Acura Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • BlackRock Investment Management's Acura Pharmaceuticals position peaked at $5K in Q2 2014.
  • 27 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.